Denise D’Andrea - Concepedia

Author

Denise D’Andrea

Also Known As

D. D'Andrea, D. D`andrea, Denise D'Andrea, Denise D'Andrea, MD, Denise D'andrea, Denise D’Andrea, Denise M D'Andrea, Denise M D’Andrea, Denise M. D'Andrea, Denise M. D’Andrea

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

CSL (United States)CSL (Australia)University of Pennsylvania Clinical Research Institute Université Paris Cité

About

Denise D’Andrea is an author at CSL (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	411
2	Pharmacology	5	5	350
3	Nephrology	2	2	165
4	Immunology	1	1	18
5	Pathology	1	1	18

Denise D’Andrea

Publications

Citations

H-Index

Page 1

	Year	Citations
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Circulation	2016	180
Trimethoprim-Induced Hyperkalemia in a Patient with AIDS Michael Choi, Pedro C. Fernandez, Asit Patnaik, New England Journal of Medicine Primary ImmunodeficiencyHyperkalemia,1,2 AidsUrologyElectrolyte DisorderImpair Renal Excretion	1993	133
Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial Pierluigi Tricoci, Denise D’Andrea, Paul A. Gurbel, Journal of the American Heart Association	2015	112
CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects Andreas Gille, Rachael Easton, Denise D’Andrea, Arteriosclerosis Thrombosis and Vascular Biology	2014	111
Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens Denise D’Andrea, Brigitte Coupaye-Gerard, Thomas R. Kleyman, Kidney International	1996	89
A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I Rachael Easton, Andreas Gille, Denise D’Andrea, The Journal of Clinical Pharmacology ThrombosisPharmaceutical ScienceCsl112 InfusionsHealthy SubjectsCardiovascular Disease	2013	84
Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma Joel Owen, Murad Melhem, Julie Passarell, Cancer Chemotherapy and Pharmacology Lymphoid NeoplasiaTherapeutic Drug MonitoringOncologyBendamustine Pharmacokinetic ProfileExposure–response Relationships	2010	67
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients Andreas Gille, Denise D’Andrea, Michael A. Tortorici, Arteriosclerosis Thrombosis and Vascular Biology	2018	65
Pharmacokinetics and Excretion of 14C-Bendamustine in Patients with Relapsed or Refractory Malignancy Anne-Charlotte Dubbelman, Hilde Rosing, Mona Darwish, Drugs in R&D	2013	39
Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study Mona Darwish, Mary Kirby, Denise D’Andrea, Clinical Therapeutics Excessive SleepinessSleep MedicineSleepSleep DisorderMultiple Doses	2010	34

Page 1